GlassScriptPhysician profile
George R Webber
NPI 1619908498
$522.04
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.13 · 2020: $43.50 · 2021: $299 · 2022: $41.17 · 2023: $57.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $120.13 | 2021 | |
| Daiichi Sankyo INC. | $63.10 | 2019-2021 | |
| Abbvie INC. | $57.65 | 2023 | Botox |
| Genentech USA, INC. | $38.65 | 2019-2020 | |
| Sanara Medtech INC. | $36.14 | 2021 | |
| Covidien LP | $34.91 | 2019-2020 | |
| Kci USA, INC. | $31.47 | 2021 | |
| Allergan, INC. | $26.89 | 2022 | |
| Merck Sharp & Dohme LLC | $26.28 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $24.38 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.56 | 2021 | |
| Angiodynamics, INC. | $15.52 | 2021 | |
| Smith+Nephew, INC. | $14.55 | 2019 | |
| Leica Microsystems INC. | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.